Inventor

BUSCHMANN HELMUT HEINRICH

DE23 patents

⚠️ This page may combine multiple inventors who share the name “BUSCHMANN HELMUT HEINRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BUSCHMANN HELMUT HEINRICH

GRUENENTHAL GMBH

6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients

Substituted amino compounds and their use as substances having an analgesic effect

Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients

6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients

Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol

Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

Separation of stereoisomeric N,N-dialkylamino-2alkyl-3-hydroxy-3-phenylalkanes

Process for producing (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol

Piperidine-2,6-diones heterocyclically substituted in the 3-position

BUSCHMANN HELMUT HEINRICH

Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof

Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

Co-crystals of duloxetine and cox-inhibitors for the treatment of pain

Salts of Tramadol and Naproxen and their crystal forms in the treatment of pain

Co-crystals of duloxetine and COX-INHIBITORs for the treatment of pain

ESTEVE LABOR DR

Co-crystals of tramadol and NSAIDs

1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof

2-′4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity

WEX MEDICAL LTD

Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

HELL WOLFGANG

Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropy1)-phenol